Lab Reagents
Human IgG antibody Laboratories manufactures the fusion peptide sequence and sars-cov reagents distributed by Genprice. The Fusion Peptide Sequence And Sars-Cov reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Peptide. Other Fusion products are available in stock. Specificity: Fusion Category: Peptide Group: Sequence And
Sequence And information
SARS-CoV-2 (COVID-19) ORF9b Peptide |
|
9191P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF9b Peptide |
SARS-CoV-2 (COVID-19) ORF3a Peptide |
|
9275P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF3a Peptide |
SARS-CoV-2 (COVID-19) ORF3b Peptide |
|
9277P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |
SARS-CoV-2 (COVID-19) ORF3b Peptide |
|
9279P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |
SARS-CoV-2 (COVID-19) ORF3b Peptide |
|
9281P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |
SARS-CoV-2 (COVID-19) ORF7a Peptide |
|
9283P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF7a Peptide |
SARS-CoV-2 (COVID-19) ORF7a Peptide |
|
9285P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF7a Peptide |
SARS-CoV-2 (COVID-19) ORF8 Peptide |
|
9287P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF8 Peptide |
SARS-CoV-2 (COVID-19) ORF8 Peptide |
|
9289P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF8 Peptide |
SARS-CoV-2 (COVID-19) ORF9c Peptide |
|
9291P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF9c Peptide |
SARS-CoV-2 (COVID-19) ORF10 Peptide |
|
9293P |
ProSci |
0.05 mg |
EUR 196.25 |
|
Description: SARS-CoV-2 (COVID-19) ORF10 Peptide |
SARS CoV E Protein |
|
abx060650-1mg |
Abbexa |
1 mg |
EUR 1692 |
|
|
SARS CoV Nucleocapsid Protein |
|
abx060652-1mg |
Abbexa |
1 mg |
EUR 1873 |
|
|
SARS-CoV Nucleocapsid Protein |
|
abx060653-1mg |
Abbexa |
1 mg |
EUR 1692 |
|
|
SARS-CoV Nucleocapsid Protein |
|
abx060654-1mg |
Abbexa |
1 mg |
EUR 1692 |
|
|
SARS-CoV Spike Protein |
|
abx060655-1mg |
Abbexa |
1 mg |
EUR 1692 |
|
|
SARS-CoV Spike Antibody |
|
3219-002mg |
ProSci |
0.02 mg |
EUR 171.82 |
|
|
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
